You may also like ...
Learn how procurement leaders in the EU are driving performance by focusing on contracts.
Access WorldCC’s highly anticipated Benchmark Report to learn how companies are protecting 8% of their bottom line through better contracting.
In this report, Gartner evaluated leading vendors based on their ability to support four key use cases. Icertis is proud to have received the highest score for Sales and Enterprise Use Cases.
Learn from World Commerce & Contracting and Icertis how retail and CPG companies are staying out in front of shifting consumer demands and supply chain dynamics with contract intelligence.
Access this exclusive report from Forrester Research examining how CLM is empowering companies to respond to a rapidly changing world by transforming contracts into strategic advantage.
Learn how the pandemic has impacted how we negotiate contracts, and where strategic contracting professionals should be focusing their attention in 2021.
Icertis is positioned as a leader in the strategic sourcing application market for its unrivaled sourcing capabilities in Quadrant Knowledge Solutions’ latest report.
In Q2 2020, WBR Insights surveyed 100 Chief Procurement Officers from across Europe to find out more about the innovative solutions they are bringing to the table to respond to COVID-19 disruptions.
Without best-in-class enterprise contract management, procurement organizations are leaving millions on the table.
Looking to digitalize your sourcing process? Read Gartner's recommendations for weighing suite vs. best-of-breed solutions and why contract-centric sourcing is becoming a best practice in procurement.
Today’s sourcing organizations need to move faster than ever to source the materials needed by their companies. Icertis contract management can help.
More than 100 procurement leaders from across Europe contributed to this report examining efforts to automate procurement systems, including ways to streamline contracting.
This comprehensive survey of 100 Clinical Operations Directors from pharma companies delves into contracting challenges that delay trials and cost millions.